Can Serum Biomarker Values from Second-Trimester Aneuploidy Screening Predict the development of Retinopathy of Prematurity in Premature Infants?
- PMID: 38854900
- PMCID: PMC11156475
- DOI: 10.14744/bej.2024.81598
Can Serum Biomarker Values from Second-Trimester Aneuploidy Screening Predict the development of Retinopathy of Prematurity in Premature Infants?
Abstract
Objectives: This study aimed to evaluate serum biomarker values measured during second-trimester aneuploidy screening in terms of their predictive ability for the development of retinopathy of prematurity (ROP) in premature infants.
Methods: This retrospective cohort study evaluated the data of 1985 idiopathic premature infants who underwent ROP screening from 2016 to 2022. The infants were divided into two groups according to the presence of ROP, and those with ROP were further evaluated in two subgroups based on the presence of proliferation. Comparisons were made concerning the serum multiple of the median values of unconjugated estriol (uE3), human chorionic gonadotropin (hCG), and alpha-fetoprotein (AFP) among aneuploidy screening biomarkers.
Results: While 1628 premature infants were in the non-ROP group, 357 were in the ROP group. Of the infants with ROP, 72 were in the proliferative ROP group and 285 in the non-proliferative ROP group. There was no significant difference in the multiple of the median values of the evaluated serum biomarkers (uE3, hCG, and AFP) between the ROP and non-ROP groups or between the proliferative ROP, non-proliferative ROP, and non-ROP groups.
Conclusion: The multiple of the median values of second-trimester aneuploidy screening serum biomarkers were not able to predict the development of ROP in premature infants. This result may have been caused by the fact that the blood tests were taken only once and in the same weeks.
Keywords: Alpha-fetoprotein; human chorionic gonadotropin; premature retinopathy; unconjugated estriol.
Conflict of interest statement
Conflict of Interest: None declared.
Similar articles
-
Is There a Relationship Between First-Trimester Aneuploidy Screening Serum Biomarker Values and Nuchal Translucency Measurements and the Development of Retinopathy of Prematurity (ROP) in Premature Infants?Cureus. 2023 Oct 13;15(10):e46969. doi: 10.7759/cureus.46969. eCollection 2023 Oct. Cureus. 2023. PMID: 37841996 Free PMC article.
-
Second Trimester Serum Biomarker Screen for Fetal Aneuploidies as a Predictor of Preterm Delivery: A Population-Based Study.Gynecol Obstet Invest. 2019;84(4):326-333. doi: 10.1159/000495614. Epub 2019 Jan 2. Gynecol Obstet Invest. 2019. PMID: 30602167
-
Obstetrical complications associated with abnormal maternal serum markers analytes.J Obstet Gynaecol Can. 2008 Oct;30(10):918-932. doi: 10.1016/S1701-2163(16)32973-5. J Obstet Gynaecol Can. 2008. PMID: 19038077 Review. English, French.
-
[The value of maternal first and second trimester serum data of β-hCG, PAPP-A, AFP and uE3 in the prediction of preeclampsia].Zhonghua Fu Chan Ke Za Zhi. 2015 Feb;50(2):101-7. Zhonghua Fu Chan Ke Za Zhi. 2015. PMID: 25877605 Chinese.
-
Retinopathy of prematurity and neurodevelopmental disabilities in premature infants.Semin Fetal Neonatal Med. 2015 Oct;20(5):346-53. doi: 10.1016/j.siny.2015.06.004. Epub 2015 Jul 30. Semin Fetal Neonatal Med. 2015. PMID: 26235349 Review.
References
-
- Bartkute K, Balsyte D, Wisser J, Kurmanavicius J. Pregnancy outcomes regarding maternal serum AFP value in second trimester screening. J Perinat Med. 2017;45:817–20. - PubMed
-
- Sirikunalai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Associations between maternal serum free beta human chorionic gonadotropin (β-hCG) levels and adverse pregnancy outcomes. J Obstet Gynaecol. 2016;36:178–82. - PubMed
-
- Settiyanan T, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2016;29:2093–7. - PubMed
-
- Nunthapiwat S, Sekararithi R, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, et al. Second trimester serum biomarker screen for fetal aneuploidies as a predictor of preterm delivery:A population-based study. Gynecol Obstet Invest. 2019;84:326–33. - PubMed
LinkOut - more resources
Full Text Sources